A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2017
Price : $35 *
At a glance
- Drugs PRX 167700 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Proximagen
- 31 Aug 2018 Biomarkers information updated
- 25 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Aug 2014 Planned End Date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.